Advanced Biomed Inc. (ADVB) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Advanced Biomed Inc.  (Nasdaq: ADVB)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Advanced Biomed's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Advanced Biomed's ROI in the third quarter of 2026?
Advanced Biomed Inc. achieved a return on average invested assets (ROI) of 81.85 % in its third quarter of 2026, this is above ADVB's average return on investment of 61.13%.
Advanced Biomed Inc. invested over the 12 months ending in its third quarter of 2026 $6 million

ROI decreased relative to the period ending Dec 31 2025, due to the decline in net income.

Within the Healthcare sector 22 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from to 70.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter		 (Mar 31 2025)
III. Quarter
Y / Y Investment Change TTM 302.45 % 808.11 % 1080.3 % - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 9 2 3 12 4
Return On Investment (TTM) 81.85 % 84.64 % -68.87 % -71.85 % -225.42 %
ADVB's Overall Ranking # 70 # # # #
Seq. Investment Change TTM 24.51 % 5.57 % 8.21 % 182.94 % 180.95 %
Seq. Net Income Change TTM 20.41 % - - - -
Net Income (TTM) in Millions 5 4 -3 -3 -4

ADVB Company Profile >> Back to ADVB Roi Comparisons >> See Annual ADVB Return On Investment



Return On Investment ADVB's Ranking
Within: No.
Industry # 1
Sector # 23
Overall # 70

Return On Investment Statistics
High Average Low
61.9 %
61.13 %
60.37 %
(Mar 31 2026)   (Dec 31 2025)







Financial Statements
Advanced Biomed's III. Quarter Investments $ 9 Millions ADVB's Balance sheet
Advanced Biomed's III. Quarter Income $ 0 Millions Quarterly ADVB's Income Statement
ADVB's Income by Division See ADVB's Income by Division


ADVB Annual Return On Investment (Jun 30 2024)
2025



Total Investments in Millions 2 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -3 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -167.28 % - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ADVB's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ADVB's Competitors
Subscribers only: Roi for Advanced Biomed's Suppliers
Subscribers only: Return On Investment for ADVB's Customers

Other Ratios
ADVB's Roa ADVB's Inventory Turnover Ratio ADVB's Growth Rates ADVB's Dividend Statistics
ADVB's Profitability Ratios ADVB's Asset Turnover Ratio ADVB's Dividend Growth
ADVB's Roe ADVB's Valuation Ratios ADVB's Financial Strength Ratios ADVB's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Silexion Therapeutics Corp  206.92 %
Kyntra Bio Inc   155.01 %
Arbutus Biopharma Corp  153.52 %
Rigel Pharmaceuticals Inc  132.72 %
Interpace Biosciences Inc   130.15 %
Oncotelic Therapeutics Inc   129.74 %
Coherus Oncology inc   128.80 %
Petros Pharmaceuticals inc   124.23 %
Quince Therapeutics Inc   114.14 %
Capforce Inc   102.27 %
Qhslab Inc   83.28 %
Advanced Biomed Inc.  81.85 %
Entera Bio Ltd   78.23 %
Pulmatrix Inc   77.85 %
Exelixis Inc   77.71 %
Ironwood Pharmaceuticals inc   72.86 %
Lensar Inc   71.13 %
Fortress Biotech Inc   70.93 %
Earth Science Tech Inc   68.75 %
Q32 Bio Inc   58.17 %
Oramed Pharmaceuticals Inc  54.33 %
Aurinia Pharmaceuticals Inc   54.02 %
Vaxart Inc   51.45 %
Escalon Medical Corp   51.07 %
Tg Therapeutics Inc   50.62 %
Zevra Therapeutics Inc   50.45 %
Idexx Laboratories Inc  50.05 %
Theravance Biopharma inc   43.85 %
Elite Pharmaceuticals Inc   43.22 %
Dariohealth Corp   40.59 %

Date modified: 2026-09-04T09:58:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.